^
1d
Clinicopathological Features, Treatment Response, and Outcome of Rosai-Dorfman Disease in Two Children. (PubMed, Clin Case Rep)
He responded poorly to cytotoxic drugs, but achieved a durable complete remission with three cycles of oral prednisolone...However, he achieved complete remission with a combination of oral methotrexate and vincristine...There is no universal standard guideline for managing Rosai-Dorfman disease. However, patients with symptomatic disease, those experiencing emergency symptoms, and cases of relapse will require medical or surgical intervention to improve their outcomes.
Journal
|
CD68 (CD68 Molecule)
|
methotrexate • vincristine • prednisolone
3d
Trial completion
|
prednisolone
8d
042011: LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis (2024-512676-36-00)
P2/3, N=1124, Active, not recruiting, St. Anna Childrens Cancer Research Institute GmbH | Not yet recruiting --> Active, not recruiting
Enrollment closed
|
cytarabine • methotrexate • cladribine • melphalan • fludarabine IV • mercaptopurine • vinblastine • prednisolone
16d
GLITZ: Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome (clinicaltrials.gov)
P=N/A, N=104, Recruiting, Post Graduate Institute of Medical Education and Research, Chandigarh | Trial completion date: Dec 2025 --> Feb 2027 | Trial primary completion date: Dec 2024 --> Jan 2027
Trial completion date • Trial primary completion date
|
prednisone • itraconazole • prednisolone
1m
Trial completion
|
prednisolone
2ms
CalciTx: CALCIGRAN FORTE AND DOSING OF IMMUNOSUPPRESSIVE DRUGS IN KIDNEY TRANSPLANT RECIPIENTS (2024-515164-30-00)
P4, N=26, Completed, Oslo University Hospital HF | Not yet recruiting --> Completed
Trial completion
|
prednisolone
2ms
SELECT-TAK: A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) (clinicaltrials.gov)
P3, N=56, Active, not recruiting, AbbVie | Trial completion date: Aug 2027 --> Aug 2028 | Trial primary completion date: Aug 2027 --> Aug 2028
Trial completion date • Trial primary completion date
|
prednisolone
2ms
New trial
|
prednisolone
3ms
Pembrolizumab-induced pan-airway mucositis with a cobblestone-like appearance: a case report. (PubMed, Jpn J Clin Oncol)
Her symptoms and endoscopic and radiologic abnormalities resolved after discontinuation of pembrolizumab and initiation of oral prednisolone, and steroids were successfully tapered without recurrence. This case highlights a rare but clinically important pattern of ICI-induced pan-airway mucositis, in which lower-airway inflammation may be initially attenuated by inhaled steroids and later become evident after extension to the upper airway; such airway irAEs should be considered in ICI-treated patients presenting with persistent or atypical upper-airway symptoms.
Journal
|
CD8 (cluster of differentiation 8)
|
Keytruda (pembrolizumab) • prednisolone
3ms
B-Cell Chronic Lymphocytic Leukemia in a Cat. (PubMed, Vet Clin Pathol)
B-cell chronic lymphocytic leukemia (B-CLL) was diagnosed, which in cats is much less frequent than T-CLL. There was a favorable response to alkylating therapy, and the cat survived for 19 months.
Journal
|
ITGB2 (Integrin Subunit Beta 2)
|
Leukeran (chlorambucil) • prednisolone
4ms
Bilateral Optic Sheath Enhancement in Giant Cell Arteritis (GCA) Presenting With Occipital Neuralgia-Like Symptoms. (PubMed, Cureus)
Although optic nerve signal changes are an uncommon manifestation of giant cell arteritis (GCA), the neurology team commenced high-dose oral prednisolone (60 mg once daily), considering GCA in the differential diagnosis...Subsequent temporal artery ultrasound findings were consistent with GCA, supporting the diagnosis. This case highlights an unusual radiological presentation of GCA and underscores the importance of early empirical treatment to prevent irreversible visual complications.
Journal
|
CRP (C-reactive protein)
|
prednisolone
4ms
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) (clinicaltrials.gov)
P1, N=141, Active, not recruiting, EMD Serono Research & Development Institute, Inc. | Recruiting --> Active, not recruiting
Enrollment closed
|
abiraterone acetate • prednisone • tuvusertib (M1774) • M9466 • prednisolone